Lucence Diagnostics

Lucence Diagnostics is creating liquid biopsies and blood tests that can be used to improve cancer detection. The earliest signs of cancer are subtle which has made early detection a challenge. Lucence is solving this problem by building sensitive blood-testing technologies that profile cancer both accurately and affordably. This includes LiquidHALLMARK®, Lucence’s liquid biopsy test that uses a sensitive next-generation sequencing assay targeting both circulating DNA and RNA to profile a patient’s unique cancer.